F. Citarda, G. Tomaselli, R. Capocaccia, S. Barcherini, and M. Crespi, Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence, Gut, vol.48, issue.6, pp.812-815, 2001.
DOI : 10.1136/gut.48.6.812

H. Shinya and W. Wolff, Morphology, Anatomic Distribution and Cancer Potential of Colonic Polyps, Annals of Surgery, vol.190, issue.6, pp.679-683, 1979.
DOI : 10.1097/00000658-197912000-00001

M. Fornasarig, M. Valentini, M. Poletti, A. Carbone, and E. Bidoli, Evaluation of the risk for metachronous colorectal neoplasms following intestinal polypectomy: a clinical, endoscopic and pathological study, Hepato-gastroenterology, vol.45, pp.1565-1572, 1998.

S. Jones, C. Wd, G. Parmigiani, F. Diehl, and N. Beerenwinkel, Comparative lesion sequencing provides insights into tumor evolution, Proceedings of the National Academy of Sciences, vol.105, issue.11, pp.4283-4288, 2008.
DOI : 10.1073/pnas.0712345105
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2393770

Y. Ma, P. Zhang, Y. J. Liu, Z. Yang, and Z. , Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation, International Journal of Cancer, vol.7, issue.9, pp.2077-2087, 2012.
DOI : 10.1002/ijc.26232

P. Gardina, T. Clark, B. Shimada, M. Staples, and Q. Yang, Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array, BMC Genomics, vol.7, issue.1, p.325, 2006.
DOI : 10.1186/1471-2164-7-325

M. Bianchini, E. Levy, C. Zucchini, V. Pinski, and C. Macagno, Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa, International Journal of Oncology, vol.29, pp.83-94, 2006.
DOI : 10.3892/ijo.29.1.83

F. Bertucci, S. Salas, S. Eysteries, V. Nasser, and P. Finetti, Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters, Oncogene, vol.23, issue.7, pp.1377-1391, 2004.
DOI : 10.1038/sj.onc.1207262

M. Skrzypczak, K. Goryca, T. Rubel, A. Paziewska, and M. Mikula, Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability, PLoS ONE, vol.5, 2010.

E. Cattaneo, E. Laczko, F. Buffoli, F. Zorzi, and M. Bianco, nonpolypoid), EMBO Molecular Medicine, vol.37, issue.6, pp.334-347, 2011.
DOI : 10.1002/emmm.201100141

B. Carvalho, A. Sillars-hardebol, C. Postma, S. Mongera, and J. Droste, Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism, Cellular Oncology, vol.34, issue.1, pp.53-63, 2012.
DOI : 10.1007/s13402-011-0065-1

A. Sillars-hardebol, B. Carvalho, M. Wit, C. Postma, and P. Delis-van-diemen, Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression, Tumor Biology, vol.169, issue.2, pp.89-96, 2010.
DOI : 10.1007/s13277-009-0012-1

H. Tang, Q. Guo, C. Zhang, J. Zhu, and H. Yang, Identification of an intermediate signature that marks the initial phases of the colorectal adenomacarcinoma transition, International Journal of Molecular Medicine, vol.26, pp.631-641, 2010.

D. Heijink, R. Fehrmann, E. De-vries, J. Koornstra, and D. Oosterhuis, A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer, Oncogene, vol.12, issue.17, pp.2026-2036, 2011.
DOI : 10.1038/onc.2010.578

K. Thorsen, F. Mansilla, T. Schepeler, B. Øster, and M. Rasmussen, Alternative Splicing of SLC39A14 in Colorectal Cancer is Regulated by the Wnt Pathway, Molecular & Cellular Proteomics, vol.10, issue.1, 2011.
DOI : 10.1074/mcp.M110.002998

E. Wang, R. Sandberg, S. Luo, I. Khrebtukova, and L. Zhang, Alternative isoform regulation in human tissue transcriptomes, Nature, vol.15, issue.7221, pp.470-476, 2008.
DOI : 10.1038/nature07509

D. Huang, B. Sherman, and R. Lempicki, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists, Nucleic Acids Research, vol.37, issue.1, pp.1-13, 2009.
DOI : 10.1093/nar/gkn923

M. Kanehisa, S. Goto, M. Furumichi, M. Tanabe, and M. Hirakawa, KEGG for representation and analysis of molecular networks involving diseases and drugs, Nucleic Acids Research, vol.38, issue.Database, pp.355-360, 2010.
DOI : 10.1093/nar/gkp896

K. Livak and T. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???????CT Method, Methods, vol.25, issue.4, pp.402-408, 2001.
DOI : 10.1006/meth.2001.1262

N. Arber, I. Shapira, J. Ratan, B. Stern, and H. Hibshoosh, Activation of c-K-ras mutations in human gastrointestinal tumors, Gastroenterology, vol.118, issue.6, pp.1045-1050, 2000.
DOI : 10.1016/S0016-5085(00)70357-X

J. Lascorz, B. Chen, K. Hemminki, and A. Försti, Consensus Pathways Implicated in Prognosis of Colorectal Cancer Identified Through Systematic Enrichment Analysis of Gene Expression Profiling Studies, PLoS ONE, vol.30, issue.4, 2011.
DOI : 10.1371/journal.pone.0018867.s010

J. Sabates-bellver, L. Van-der-flier, M. De-palo, E. Cattaneo, and C. Maake, Transcriptome Profile of Human Colorectal Adenomas, Molecular Cancer Research, vol.5, issue.12, pp.1263-1275, 2007.
DOI : 10.1158/1541-7786.MCR-07-0267

M. Heslin, Y. J. Johnson, M. Weiss, H. Diasio, and R. , Role of Matrix Metalloproteinases in Colorectal Carcinogenesis, Annals of Surgery, vol.233, issue.6, pp.786-792, 2001.
DOI : 10.1097/00000658-200106000-00008

Y. Van-den-berg, S. Osanto, P. Reitsma, and H. Versteeg, The relationship between tissue factor and cancer progression: insights from bench and bedside, Blood, vol.119, issue.4, pp.924-932, 2012.
DOI : 10.1182/blood-2011-06-317685

Y. Lin, Y. Furukawa, T. Tsunoda, C. Yue, and K. Yang, Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas, Oncogene, vol.21, issue.26, pp.4120-4128, 2002.
DOI : 10.1038/sj.onc.1205518

O. Galamb, F. Sipos, S. Spisák, B. Galamb, and T. Krenács, Potential biomarkers of colorectal adenoma?dysplasia?carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes, Cellular Oncology, vol.31, pp.19-29, 2009.

O. Galamb, B. Wichmann, F. Sipos, S. Spisák, and T. Krenács, Dysplasia-Carcinoma Transition Specific Transcripts in Colonic Biopsy Samples, PLoS ONE, vol.25, issue.11, p.48547, 2012.
DOI : 10.1371/journal.pone.0048547.s001

A. Lam, K. Ong, and Y. Ho, Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity, Human Pathology, vol.39, issue.4, pp.599-604, 2008.
DOI : 10.1016/j.humpath.2007.09.001

T. Romanuik, T. Ueda, N. Le, S. Haile, and T. Yong, Novel Biomarkers for Prostate Cancer Including Noncoding Transcripts, The American Journal of Pathology, vol.175, issue.6, pp.2264-2276, 2009.
DOI : 10.2353/ajpath.2009.080868

N. Miyoshi, H. Ishii, M. Sekimoto, Y. Doki, and M. Mori, RGS16 Is a Marker for Prognosis in Colorectal Cancer, Annals of Surgical Oncology, vol.94, issue.12, pp.3507-3514, 2009.
DOI : 10.1245/s10434-009-0690-3

R. Hubner, K. Muir, J. Liu, R. Logan, and M. Grainge, Genetic Variants of UGT1A6 Influence Risk of Colorectal Adenoma Recurrence, Clinical Cancer Research, vol.12, issue.21, pp.6585-6589, 2006.
DOI : 10.1158/1078-0432.CCR-06-0903

B. Jovov, F. Araujo-perez, C. Sigel, J. Stratford, and A. Mccoy, Differential Gene Expression between African American and European American Colorectal Cancer Patients, PLoS ONE, vol.61, issue.1, 2012.
DOI : 10.1371/journal.pone.0030168.s002

Q. Wang, Y. Wen, D. Li, J. Xia, and C. Zhou, Upregulated INHBA expression is associated with poor survival in gastric cancer, Medical Oncology, vol.17, issue.1, pp.77-83, 2012.
DOI : 10.1007/s12032-010-9766-y

C. Vién and . O-p-o-i-sv, ) Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells, Molecular Cancer, vol.7, p.14

Y. Kim, Y. Ahn, K. Song, J. Kang, and J. Lee, Overexpression and ??-1,6-N-Acetylglucosaminylation-initiated Aberrant Glycosylation of TIMP-1: A "DOUBLE WHAMMY" STRATEGY IN COLON CANCER PROGRESSION, Journal of Biological Chemistry, vol.287, issue.39, pp.32467-32478, 2012.
DOI : 10.1074/jbc.M112.370064

Y. Ahn, K. Kim, P. Shin, E. Ji, and H. Kim, Identification of Low-Abundance Cancer Biomarker Candidate TIMP1 from Serum with Lectin Fractionation and Peptide Affinity Enrichment by Ultrahigh-Resolution Mass Spectrometry, Analytical Chemistry, vol.84, issue.3, pp.1425-1431, 2012.
DOI : 10.1021/ac2024987

N. Jeffery, M. Mclean, E. El-omar, and G. Murray, The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers, Histopathology, vol.88, issue.7, pp.820-828, 2009.
DOI : 10.1111/j.1365-2559.2009.03301.x

J. Daum, J. Wren, J. Daniel, S. Sivakumar, and J. Mcavoy, Ska3 Is Required for Spindle Checkpoint Silencing and the Maintenance of Chromosome Cohesion in Mitosis, Current Biology, vol.19, issue.17, pp.1467-1472, 2009.
DOI : 10.1016/j.cub.2009.07.017

M. Garnett, J. Mansfeld, C. Godwin, T. Matsusaka, and J. Wu, UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit, Nature Cell Biology, vol.17, issue.11, pp.1363-1369, 2009.
DOI : 10.1038/ncb1983

T. Hirota, N. Kunitoku, T. Sasayama, T. Marumoto, and D. Zhang, Aurora-A and an Interacting Activator, the LIM Protein Ajuba, Are Required for Mitotic Commitment in Human Cells, Cell, vol.114, issue.5, pp.585-598, 2003.
DOI : 10.1016/S0092-8674(03)00642-1

J. Huang, D. Zheng, F. Qin, N. Cheng, and H. Chen, Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling, Journal of Clinical Investigation, vol.120, issue.1, pp.223-241, 2010.
DOI : 10.1172/JCI38012DS1

N. Yan, S. Zhang, Y. Yang, L. Cheng, and C. Li, Therapeutic upregulation of Class A scavenger receptor member 5 inhibits tumor growth and metastasis, Cancer Science, vol.3, issue.9, pp.1631-1639, 2012.
DOI : 10.1111/j.1349-7006.2012.02350.x

A. Khamas, T. Ishikawa, K. Shimokawa, K. Mogushi, and S. Iida, Screening for epigenetically masked genes in colorectal cancer using 5-Aza-29- deoxycytidine, microarray and gene expression profile, Cancer Genomics- Proteomics, vol.9, pp.67-75, 2012.

D. Fabio, F. Alvarado, C. Majdan, A. Gologan, A. Voda et al., Underexpression of Mineralocorticoid Receptor in Colorectal Carcinomas and Association with VEGFR-2 Overexpression, Journal of Gastrointestinal Surgery, vol.106, issue.11, pp.1521-1528, 2007.
DOI : 10.1007/s11605-007-0234-8

G. Bommer, DRO1, a Gene Down-regulated by Oncogenes, Mediates Growth Inhibition in Colon and Pancreatic Cancer Cells, Journal of Biological Chemistry, vol.280, issue.9, pp.7962-7975, 2004.
DOI : 10.1074/jbc.M412593200

M. Kanda, S. Nomoto, Y. Okamura, M. Hayashi, and M. Hishida, Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma, Molecular Carcinogenesis, vol.67, issue.8, pp.571-579, 2011.
DOI : 10.1002/mc.20735

T. Cui, Y. Chen, T. Knösel, L. Yang, and K. Zöller, Human complement factor H is a novel diagnostic marker for lung adenocarcinoma, International Journal of Oncology, 2011.

X. Jiang, J. Tan, J. Li, S. Kivimä-e, and X. Yang, DACT3 Is an Epigenetic Regulator of Wnt/??-Catenin Signaling in Colorectal Cancer and Is a Therapeutic Target of Histone Modifications, Cancer Cell, vol.13, issue.6, pp.529-541, 2008.
DOI : 10.1016/j.ccr.2008.04.019

A. Hamm, J. Veeck, N. Bektas, P. Wild, and A. Hartmann, Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis, BMC Cancer, vol.67, issue.5, p.25, 2008.
DOI : 10.1016/S0002-9297(07)62934-6

H. Zhang, E. Widegren, D. Wang, and X. Sun, SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer, Tumor Biology, vol.41, issue.6, pp.1225-1231, 2011.
DOI : 10.1007/s13277-011-0226-x

N. Miyoshi, H. Ishii, K. Mimori, Y. Takatsuno, and H. Kim, Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis, British Journal of Cancer, vol.294, issue.10, pp.1664-1670, 2009.
DOI : 10.1002/ijc.23321

F. André, S. Michiels, P. Dessen, V. Scott, and V. Suciu, Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis, The Lancet Oncology, vol.10, issue.4, pp.381-390, 2009.
DOI : 10.1016/S1470-2045(09)70024-5

S. Pal, R. Gupta, and R. Davuluri, Alternative transcription and alternative splicing in cancer, Pharmacology & Therapeutics, vol.136, issue.3, 2012.
DOI : 10.1016/j.pharmthera.2012.08.005